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and Endovascular Surgery
P. Grundtner,* A. Assadian, C. Senekowitsch, H. Ptakovsky, H. Mendel and
G.W. Hagmu¨llerDepartment of General and Vascular Surgery, Wilhelminenspital Vienna, Montleartstraße 37,
1160 Vienna, AustriaThe Sack–Barabas syndrome, the vascular type of Ehlers–Danlos syndrome type IV, is considered the most serious form of
Ehlers–Danlos syndrome as the vascular system is prone to aneurysmatic degeneration and rupture without preference of
anatomic regions. We report a patient with Sack–Barabas syndrome who was treated by one vascular surgeon for 16 years,
from the first of many operations until death at the age of 27.Keywords: Ehlers–Danlos syndrome type IV; Sack–Barabas syndrome; Aneurysms.Introduction
The German physician Georg Sack and the British
surgeon A. P. Barabas first described the syndrome in
the 20th century.1,2 Ehlers–Danlos syndrome is a group
of inherited disorders affecting the connective tissue.3–5
The vascular type is considered one of themost serious
forms of Ehlers–Danlos syndrome because blood
vessels and organs are prone to rupture. This
condition was formerly called type IV Ehlers–Danlos
syndrome, and is now known as Sack–Barabas
syndrome (SBS). Patients with this disorder have
thin, fragile skin that bruises easily. Hands and feet
may have an aged appearance. Unlike patients with
other forms of Ehlers–Danlos syndrome, patients with
the vascular type have skin that is soft but not overly
stretchy. Facial features are often distinctive, including
protruding eyes, a thin nose and lips, sunken cheeks,
and a small chin. Other signs of the disorder include
hypermobility of joints, tearing of tendons and
muscles, painfully swollen veins in the legs, lung
collapse, and slow wound healing following injury oring author. Dr P. Grundtner, MD, Department of
Vascular Surgery, Wilhelminenspital Vienna, Mon-
7, 1160 Vienna, Austria.
: grpe@utanet.at
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hip dislocations and clubfeet. Unpredictable ruptures
of arteries and organs are serious complications of SBS
syndrome.6,7,8 Ruptured arteries, causing internal
bleeding, stroke, or shock, are the most common
cause of death in patients with SBS. Rupture of the
intestine is seen in 25–30% of affected individuals and
tearing of the uterus during pregnancy affects 2–3% of
women.9,10 Although these symptoms are rare in
childhood, more than 80% of patients experience
severe complications by the age of 40. Teenage boys
are at high risk for arterial rupture, often fatal. Herein,
we report the case of a patient initially presenting at
the age of 11 with an iliac aneurysm rupture and life
long follow-up and interventions.Case Report
The first presentation of the patient to a vascular
surgeon was in 1988. The vascular surgeon on call
(GWH) was called to assess an 11 years old boy with a
painful pulsatile mass in his left groin. CT-scan and
angiography (Fig. 1) showed bilateral iliac artery
aneurysms, with a rupture on the left. In addition,EJVES Extra 9, 107–110 (2005)
doi:10.1016/j.ejvsextra.2005.02.021, available online at http://www.sciencedirect.com onD license. 
Fig. 1. (a) Abdominal CT: iliac aneurysm in rupture. (b)
Selective angiography: diffuse SMA-aneurysm. (c) Lienal
artery aneurysms.
P. Grundtner et al.108multiple asymptomatic aneurysms of the superior
mesenteric, the common hepatic and both renal
arteries were found. The ruptured iliac artery was
repaired with an emergency aorto-bifemoral bypass
graft. After a recovery period of 3 months the intestinalEJVES Extra Vol 9, May 2005aneurysms were treated by resection and PTFE graft
interposition of the superior mesenteric, the common
hepatic and the right renal artery. The aneurysmatic
splenic artery was ligated, no splenectomy was
necessary. The resected aneurysm walls were histo-
logically analysed and SBS was verified. Our patient
was a sporadic case of SBS, caused by new mutations
in one copy of the COL3A1 gene as described by
Hassan et al.6 Screening of all family members was
negative.
The right renal artery and celiac axis interposition
grafts occluded after 2 weeks. Right nephrectomy was
necessary due to major renal necrosis. The blocked
celiac axis graft was managed conservatively in the
absence of major liver ischaemia. The patient recov-
ered and was discharged home on anti-hypertensive
therapy.
In 1990 the patient suffered synchronous pulsating
neck- and headaches. Bilateral diffuse extracranial
vertebral aneurysms were found and were treated by
carotid vertebral C1-bypasses and ligation of the
aneurysm (Fig. 2).
In 1997 a Hemobahn stentgraftw (W. L. Gore
Flagstaff, USA) was implanted in a left brachial artery
aneurysm. The cubital artery on the same side needed
to be bridged with a PTFE-graft because of a large
aneurysm causing severe discomfort. The following
year the patient developed left leg claudication,
caused by a superficial femoral artery aneurysm.
This was treated with a Hemobahn stentgraftw,
implanted by a cut down incision into the common
femoral artery.
In 1999 the patient returned with therapy-resistant
pulsating left sided headache, caused by a sympto-
matic aneurysm of the left intrasphenoideal internal
carotid artery. Exclusion with a Hemobahn stentgraftw
through the common carotid artery was attempted
unsuccessfully. The aneurysm had to be excluded by
coil embolisation and the internal carotid artery was
ligated. The patient suffered from a transient aphasia
lasting 24 h. In the same year claudication of the right
leg required a Hemobahn stentgraftw to be implanted
in an aneurysmatic right common and superficial
femoral artery. The claudication was caused by
thromboembolic events originating from in the
femoral aneurysms.
The last interventions were in 2001. Motor and
sensory dysfunction of the left arm required a left
brachial artery redo—PTFE-graft. Large right subcla-
vian and brachial artery aneurysms (Fig. 3) were
stented with a Hemobahnw prosthesis due to impend-
ing rupture.
In 2004, the patient was 27 years old. He suffered
from claudication (50 m walking distance) since 1998,
Fig. 2. (a) Bilateral vertebral artery aneurysms. (b) Common
carotid vertebral bypass left side (C1-bypass).
Fig. 4.Aneurysms of the lower extremities: common femoral,
superficial femoral, profund femoral and popliteal arteries.
Patient with Sack–Barabas Syndrome 109without the possibility of revascularisation. However,
he was content with his quality of life and working
regularly. Except aspirin, he was on no medication.
Angiography of the visceral arteries and the extremi-
ties performed in July 2004 did not show any vascular
abnormalities requiring surgery (Fig. 4).Fig. 3.Hemobahn stentgrafts of the right subclavian-axillary
and brachial arteries.In August 2004 the patient was admitted with
severe epigastric pain, hypotension and collapse. An
abdominal CT (Fig. 5) showed free fluid in the left
upper abdomen and calcified aneurysms of the upper
mesenteric artery and celiac axis. The patient was
immediately transferred to theatre for emergency
surgery of a suspected rupture of the splenic artery
aneurysm ligated in 1988. The patient died on the way
to theatre, 16 years after his first operation. All surgical
interventions over this period were performed by one
vascular surgeon (Fig. 6).Discussion
Sack–Barabas syndrome, the vascular manifestation ofFig. 5. Native abdominal CT: calcified upper intestinal
aneurysms, suspicious enhanced free liquid between them
(ruptured aneurysm of the lienal artery).
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Fig. 6. Native abdominal CT: calcified upper intestinal
aneurysms, suspicious enhanced free liquid between them
(ruptured aneurysm of the lienal artery).
P. Grundtner et al.110Ehlers–Danlos syndrome is rare and has an estimated
prevalence of one in 100,000–200,000 and is caused by
mutations in the COL3A1 gene.
The protein determined by the COL3A1 gene is
used to assemble larger type III collagen molecules.
Collagens provide structure and strength to connec-
tive tissue throughout the body. Type III collagen is
mostly found in skin, blood vessels, and internal
organs. If the structure or production of type III
collagen is altered by a mutation in the COL3A1 gene,
collagen fibrils cannot be assembled properly in these
tissues, and the symptoms of Ehlers–Danlos syndrome
result.3–5
The condition is inherited in an autosomal domi-
nant pattern, which means only one copy of an altered
gene is needed to cause the disorder. About half of all
cases are inherited from a parent who has the
condition. The other half of cases occurs in patients
whose families have no history of the disorder. These
sporadic cases are caused by new mutations in one
copy of the COL3A1 gene.
The tests to verify the disease are biochemical
samples such as collagen typing (performed on a skin
biopsy sample) or collagen gene mutation testing.
There is no cure for Ehlers–Danlos syndrome, so
individual problems and symptoms must be evalu-
ated and treated accordingly. The initial clinical
manifestation of vascular problems in patients withEJVES Extra Vol 9, May 2005SBS is early, about 25% have their first presentation at
age 20 and more than 80% of patients in a large cohort
have had at least one complication by the age of 40.
The median survival of the entire cohort was only 48
years.3
Genetic counselling is recommended for prospec-
tive parents with a family history of Ehlers–Danlos
syndrome. Recognition of this syndrome is necessary
because of increased risk of premature death due to
rupture of arteries, bowel or uterine rupture in
pregnant women with a reported mortality rate of
50%.3
The key for managing these patients is to be aware
of their disease and escort them through compli-
cations, plan surgical procedures and pregnancy in
affected women. As the reported case demonstrates,
close follow-up and planning of interventions can
significantly prolong and maintain the quality of live
of a patient with this disease.References
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